{"transactions":[{"id":4633699,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-10-02T00:23:08.000Z","date":"2026-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":4086,"price":60,"value":245160.0,"ownership":{"direct":true},"balance_after":47732,"source":{"system":"sec-edgar","filing":"0001628280-26-064272","document":"wk-form4_1790886185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026064272/wk-form4_1790886185.xml","form_type":"4"}},{"id":785327,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-05-11T21:01:13.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":3281,"price":53.85,"value":176681.85,"ownership":{"direct":true},"balance_after":51818,"source":{"system":"sec-edgar","filing":"0001628280-26-033639","document":"wk-form4_1778533271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026033639/wk-form4_1778533271.xml","form_type":"4"}},{"id":835669,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T17:39:42.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":45600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":45600,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":45600},"source":{"system":"sec-edgar","filing":"0001628280-26-019266","document":"wk-form4_1773855579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019266/wk-form4_1773855579.xml","form_type":"4"}},{"id":835668,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:39:42.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1629,"price":56.05,"value":91305.45,"ownership":{"direct":true},"balance_after":55099,"source":{"system":"sec-edgar","filing":"0001628280-26-019266","document":"wk-form4_1773855579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019266/wk-form4_1773855579.xml","form_type":"4"}},{"id":835667,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:39:42.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":19150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."}],"balance_after":56728,"source":{"system":"sec-edgar","filing":"0001628280-26-019266","document":"wk-form4_1773855579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019266/wk-form4_1773855579.xml","form_type":"4"}},{"id":880225,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:39:05.000Z","date":"2026-02-26","kind":"sale","planned":false,"acquired":false,"shares":6326,"price":60.3758,"value":381937.3108,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $60.36 to $60.51. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price"}],"balance_after":37578,"source":{"system":"sec-edgar","filing":"0001628280-26-012539","document":"wk-form4_1772156343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012539/wk-form4_1772156343.xml","form_type":"4"}},{"id":905768,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:54:26.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":398,"price":45.535,"value":18122.93,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":43904,"source":{"system":"sec-edgar","filing":"0001628280-26-008218","document":"wk-form5_1771026863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008218/wk-form5_1771026863.xml","form_type":"5"}},{"id":1027941,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2025-10-02T20:33:15.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3304,"price":54.16,"value":178944.64,"ownership":{"direct":true},"balance_after":43506,"source":{"system":"sec-edgar","filing":"0002038768-25-000007","document":"wk-form4_1759437191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000203876825000007/wk-form4_1759437191.xml","form_type":"4"}},{"id":1201344,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:23:32.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":41170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":41170,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":41170},"source":{"system":"sec-edgar","filing":"0001048477-25-000033","document":"wk-form4_1742336605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000033/wk-form4_1742336605.xml","form_type":"4"}},{"id":1201343,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:23:32.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":17750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":46810,"source":{"system":"sec-edgar","filing":"0001048477-25-000033","document":"wk-form4_1742336605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000033/wk-form4_1742336605.xml","form_type":"4"}},{"id":1397073,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-10-01T20:51:26.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":49850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on September 30, 2025 and 1/48th per month thereafter."}],"balance_after":49850,"derivative":{"exercise_price":70.29,"exercise_date":"2025-09-30","expiration_date":"2034-09-29","underlying":"Common Stock","underlying_shares":49850},"source":{"system":"sec-edgar","filing":"0001048477-24-000146","document":"wk-form4_1727815879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000146/wk-form4_1727815879.xml","form_type":"4"}},{"id":1397072,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-10-01T20:51:26.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":7870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on September 30, 2024. Price not applicable."}],"balance_after":29060,"source":{"system":"sec-edgar","filing":"0001048477-24-000146","document":"wk-form4_1727815879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000146/wk-form4_1727815879.xml","form_type":"4"}},{"id":1397071,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-10-01T20:51:26.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":21190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on September 30, 2024. Price not applicable."}],"balance_after":21190,"source":{"system":"sec-edgar","filing":"0001048477-24-000146","document":"wk-form4_1727815879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000146/wk-form4_1727815879.xml","form_type":"4"}}]}